HarborPath, FFF Enterprises partner for naloxone distribution effort

HarborPath, a North Carolina-based nonprofit organization providing life-saving medications in 17 states, announced a partnership with FFF Enterprises to distribute naloxone to combat the opioid crisis.

In a press release, HarborPath stated its aim to bolster local efforts by introducing a multistate approach to deploying naloxone through nonprofit organizations, county health departments, college and university health centers, or directly to consumers.

More than 100,000 Americans died of opioid overdoses in the 12 months ending April 2021, up sharply from about 78,000 during the same period the year before, according to the U.S. CDC data presented in the release.

“We selected FFF Enterprises as our exclusive distributor because they share our same values,” Ken Trogdon, president of HarborPath, stated in the release. “By using our collective expertise and resources to beat this horrible crisis, we will save the lives of those caught in the grip of addiction.”

With facilities located in North Carolina, Texas and California, FFF Enterprises will act as exclusive distributor through its subsidiary, Nufactor, which offers naloxone free through a discreet, secure, direct-to-consumer model. HarborPath will act as the nonprofit organization contracting directly with states, counties, cities and other nonprofits to provide this life-saving medication.

Most recently, HarborPath awarded a grant to fund a full-time position in Kentucky for the nonprofit Operation UNITE to focus on making naloxone more available and accessible throughout a 32-county area ravaged by the opioid crisis.

“We are pleased HarborPath selected us to work with them on this effort to save lives affected by the opioid crisis,” Patrick M. Schmidt, CEO of FFF Enterprises said in the release. “The primary goal of providing citizens and communities suffering from opioid use disorder easier access to a life-saving medication is something we can wholeheartedly support.”